Sweden’s RWD ecosystem is one of the most powerful globally — rich in coverage, high in trust, and fully linkable across registers via the personal identity number unique to every resident.
Thousands of peer-reviewed publications demonstrate its value.
With >100 disease-specific registries, laboratory data, national databases, and healthcare records, Sweden supports rigorous, longitudinal studies across disease areas, clinical outcomes, and health economics.
Regulatory-grade evidence-globally accepted 🏛️
Swedish data enables regulatory-grade evidence generation with global transportability.
▶️ Meets EMA standards for non-interventional RWE
▶️ Accepted in EMA and FDA submissions, including PASS
▶️ 20% of EMA PASS studies included Nordic data in 2024
High- quality, fit-for-purpose dataÂ
• Near-complete population coverage
• High concordance across datasets
• Hospital, primary care, and disease-specific registers
• Severity, quality of care, quality of life, productivity loss
• Up to 50 years of longitudinal follow-up
Well-designed studies using Swedish RWD can generate evidence that matters — locally and internationally.
đź’ˇAre you using Nordic registers to their full potential?